Shanghai Fosun Pharmaceutical (Group) Co Ltd 2022 AR2
The report highlights Shanghai Fosun Pharmaceutical (Group) Co., Ltd.'s progress in sustainability and healthcare innovation in 2022. The company achieved a revenue of RMB 43,811 million, representing a 12.73% year-on-year increase, driven by new and innovative products. Fosun Pharma advanced its global R&D, investing RMB 5,885 million in R&D expenditures. In terms of environmental performance, the company reduced its carbon emission intensity by 4.35% and comprehensive energy consumption intensity by 7.77% compared to 2021. Additionally, the company continued its global malaria-control efforts, supplying over 280 million vials of its self-developed Artesun to cure severe malaria patients worldwide.
Company: Shanghai Fosun Pharmaceutical (Group) Co Ltd
Sector: Manufacturing
Country: China
Year: 2022
Type: AR2
Pages: 347
Back to company
Shanghai Fosun Pharmaceutical (Group) Co Ltd
Annual Report
The report highlights Shanghai Fosun Pharmaceutical (Group) Co., Ltd.'s progress in sustainability and healthcare innovation in 2022. The company achieved a revenue of RMB 43,811 million, representing a 12.73% year-on-year increase, driven by new and innovative products. Fosun Pharma advanced its global R&D, investing RMB 5,885 million in R&D expenditures. In terms of environmental performance, the company reduced its carbon emission intensity by 4.35% and comprehensive energy consumption intensity by 7.77% compared to 2021. Additionally, the company continued its global malaria-control efforts, supplying over 280 million vials of its self-developed Artesun to cure severe malaria patients worldwide.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Workplace Fatalities
Employees